Article ID Journal Published Year Pages File Type
10220790 Journal of Cataract & Refractive Surgery 2018 6 Pages PDF
Abstract
In this ex vivo study, ROCK inhibitor reduced endothelial loss and thus, could be used to limit or slow down CEC loss. Rho-associated kinase inhibitor might be used before cataract surgery, especially in high risk patients. This might be a promising new method for preventing pseudophakic bullous keratopathy.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , , , , ,